TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›AIBT›Financials
Annual statements · SEC XBRL · FY2018 – FY2025

AIBOTICS, INC. (AIBT) financials

Income statement

AIBOTICS, INC. (AIBT) income statement, annual, from SEC filings
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$0.00$0.00————$0.00$2.18K
Gross profit$0.00$0.00————$0.00$2.18K
Gross margin———————100.0%
Operating income-$186K-$252K-$14.2K-$2.67M-$1.74M-$617K-$1.63M-$1.84M
Operating margin———————-84501.7%
Net income$61.2K$4.80K-$16.0K-$2.82M-$2.61M-$1.18M-$1.85M-$2.22M
Net margin———————-101500.3%
EPS (diluted)$0.00$0.00——————

Cash flow

AIBOTICS, INC. (AIBT) cash flow, annual, from SEC filings
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-$68.5K$98.7K-$14.3K-$235K-$657K-$107K-$259K-$458K
Capital expenditures——$0.00$2.75K$0.00———
Free cash flow——-$14.3K-$238K-$657K———

Balance sheet

AIBOTICS, INC. (AIBT) balance sheet, annual, from SEC filings
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$611K$0.00$111K$1.27M$386K$279K$185K$256K
Total assets$1.50M$1.22M$111K$1.27M$387K$2.22M$1.46M$875K
Total liabilities$853K$563K$127K$930K$1.28M$4.25M$4.85M$4.83M
Shareholders' equity$647K-$720.00-$16.2K$52.0K-$891K-$2.03M-$3.39M-$3.96M
Retained earnings$608K$613K-$29.2K-$2.85M-$7.78M-$8.96M-$10.8M-$13.0M
Shares (wtd avg diluted)12.4M12.4M12.9M14.0M14.9M14.9M40.0M487M

Every figure is extracted from AIBOTICS, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is AIBOTICS, INC.'s annual revenue?
AIBOTICS, INC. (AIBT) reported $2.18K of revenue for fiscal year 2025, per its annual report filed with the SEC.
Is AIBOTICS, INC. profitable?
Not in FY2025 — AIBT reported a net loss of $2.22M, per SEC filings.
Does AIBT pay a dividend?
AIBOTICS, INC. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full AIBT analysis — verdict, score & filings →Is AIBT a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.